Bridging Science & Care
to Combat Myopia Worldwide
Who We Are
The Myopia Society was established in 2021 by the late Professor Ramin Tadayoni to address one of the most pressing global health challenges of our time.
The Myopia Society unites clinicians, researchers, and industry partners to address the growing burden of myopia and its vision-threatening complications.
— Founder & Visionary
Mission & vision
Our mission is built on three pillars:
Integration
Merging fundamental science, clinical medicine, and industrial innovation into a unified, coordinated response to the myopia epidemic.
Collaboration
Providing a platform for global experts to share data, coordinate research efforts, and build international consensus on management protocols.
Education
Translating scientific progress into medical education resources and public health tools to optimise patient care pathways worldwide.
Core activities
By providing a robust infrastructure and a collaborative platform, the Society coordinates exchanges between professionals dedicated to studying myopia and its complications. Our core activities include:
Consensus & meetings
Annual meetings and consensus sessions focused on cutting-edge myopia research and treatment standards.
Medical education
Continuous medical training, webinars, and pedagogical materials for healthcare professionals and the public.
Research support
Study grants and travel fellowships supporting clinical and experimental research programs in myopia.
Patient care
Enhancing care pathways for patients suffering from myopia and its associated risks, including macular disease.
Board of Directors
The Society was established by four founding members who serve as the initial Board of Directors:
Prof. Kyoko Ohno-Matsui
(Japan)
Dr. Richard Spaide
(USA)
Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, macular degeneration, macular holes, macular pucker, diabetic retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of retinal diseases. He has given lectures around the world.
Dr. Aude Couturier
(France)
Dr. Aude Couturier is Professor of Ophthalmology at Université Paris Cité and Deputy Head of the Department of Ophthalmology at Lariboisière and Saint-Louis Hospitals. She specializes in vitreoretinal surgery, laser diagnosis and treatment of retinal diseases, and retinal imaging.
Prof. Gemmy Cheung
(Singapore)
Professor Gemmy Cheung is currently the Senior Consultant of the Medical Retina Department and Cataract & Comprehensive Ophthalmology Department at Singapore National Eye Centre. She is also the Head of the Retina Research Group at the Singapore Eye Research Institute (SERI) and Professor of Duke-NUS Medical School in Singapore.
International faculty
The Society is supported by a global network of invited experts:
Europe
Ian Flitcroft, Adnan Tufail, Serge Resnikoff, Jost Jonas, Caroline Klaver, Elise Philippakis, Jose Maria Ruiz-Moreno.
Asia-Pacific
Mingguang He, Jason Yam, Pei-Chang Wu, Yaxing Wang, Timothy Lai, Chi-Chun Lai, Audrey Chia, Shu Yen Lee, Tien Yin Wong, Seang Mei Saw, Marcus Ang, Foo Li Lian, Gavin Tan.
Tribute to a Visionary
Professor
Ramin Tadayoni
(1970–2024)
"Innovation is only meaningful if it is shared and placed at the service of everyone’s vision."
The Myopia Society stands as a testament to the vision of Professor Ramin Tadayoni. Ramin was a unique leader who dedicated his career to improving the care of highly myopic patients.
In 2021, Professor Ramin Tadayoni founded the Myopia Society with a clear vision: myopia is not just a refractive error, but a complex disease requiring a unified global response.
A world-renowned clinician, brilliant researcher, and devoted mentor, Ramin was a master at building bridges between diverse fields. He recognized early on the necessity of a project that could match the scale of the impending myopia epidemic in Europe and globally. His efforts led to the creation of the French Myopia Institute, aiming to develop innovative therapies and limit the risk of blindness.
His legacy lives on through this society, which continues his work in transforming scientific discovery into concrete solutions for patients. Under the leadership of our Board, we remain committed to the excellence and humanity he championed.
Ramin was an inspiring mentor and scientist, his light continues to guide the Society as we carry his voice and mission forward.